Pearson E - Search Results

1

Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia - A Narrative Review.

Witham MD, Granic A, Pearson E, Robinson SM, Sayer AA. Witham MD, et al. Among authors: pearson e. Drugs Aging. 2023 Aug;40(8):703-719. doi: 10.1007/s40266-023-01042-4. Epub 2023 Jul 24. Drugs Aging. 2023. PMID: 37486575 Free PMC article. Review.

2

Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.

George PS, Pearson ER, Witham MD. George PS, et al. Among authors: pearson er. Diabet Med. 2012 Aug;29(8):e142-50. doi: 10.1111/j.1464-5491.2012.03672.x. Diabet Med. 2012. PMID: 22486204 Review.

3

Personalized medicine in diabetes: the role of 'omics' and biomarkers.

Pearson ER. Pearson ER. Diabet Med. 2016 Jun;33(6):712-7. doi: 10.1111/dme.13075. Diabet Med. 2016. PMID: 26802434 Free PMC article. Review.

4

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes.

Donnelly LA, Doney AS, Hattersley AT, Morris AD, Pearson ER. Donnelly LA, et al. Among authors: pearson er. Diabet Med. 2006 Feb;23(2):128-33. doi: 10.1111/j.1464-5491.2005.01755.x. Diabet Med. 2006. PMID: 16433709

5

Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study.

Donnelly LA, Morris AD, Pearson ER. Donnelly LA, et al. Among authors: pearson er. Diabetes Obes Metab. 2009 Apr;11(4):338-42. doi: 10.1111/j.1463-1326.2008.00973.x. Diabetes Obes Metab. 2009. PMID: 19267712

6

Treating type 2 diabetes in youth: a depressing picture.

Pearson ER. Pearson ER. J R Coll Physicians Edinb. 2012;42(3):228. doi: 10.4997/JRCPE.2012.309. J R Coll Physicians Edinb. 2012. PMID: 22953318 Clinical Trial.

7

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.

Dujic T, Causevic A, Bego T, Malenica M, Velija-Asimi Z, Pearson ER, Semiz S. Dujic T, et al. Among authors: pearson er. Diabet Med. 2016 Apr;33(4):511-4. doi: 10.1111/dme.13040. Epub 2015 Dec 24. Diabet Med. 2016. PMID: 26605869 Free PMC article.

8

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol.

Angwin C, Jenkinson C, Jones A, Jennison C, Henley W, Farmer A, Sattar N, Holman RR, Pearson E, Shields B, Hattersley A; MASTERMIND consortium. Angwin C, et al. Among authors: pearson e. BMJ Open. 2020 Dec 21;10(12):e042784. doi: 10.1136/bmjopen-2020-042784. BMJ Open. 2020. PMID: 33371044 Free PMC article.

9

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.

Dawed AY, Mari A, Brown A, McDonald TJ, Li L, Wang S, Hong MG, Sharma S, Robertson NR, Mahajan A, Wang X, Walker M, Gough S, Hart LM', Zhou K, Forgie I, Ruetten H, Pavo I, Bhatnagar P, Jones AG, Pearson ER; DIRECT consortium. Dawed AY, et al. Lancet Diabetes Endocrinol. 2023 Jan;11(1):33-41. doi: 10.1016/S2213-8587(22)00340-0. Lancet Diabetes Endocrinol. 2023. PMID: 36528349 Free article.

10

Generation, validation and humanisation of a novel insulin resistant cell model.

Logie L, Ruiz-Alcaraz AJ, Schofield CJ, Hundal HS, Feuerstein GZ, Brady JD, Crowther D, Tommasi AM, Grierson CE, Shepherd B, Morris AD, Hansen MK, Pearson E, Sutherland C. Logie L, et al. Among authors: pearson e. Biochem Pharmacol. 2010 Oct 1;80(7):1042-9. doi: 10.1016/j.bcp.2010.06.011. Epub 2010 Jun 23. Biochem Pharmacol. 2010. PMID: 20599791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

815 results

Search Page